| Friday, November 29th, 2024 | |
|---|---|
| 08.30 – 08.45 | Welcome Prof. Dr. Jörg Fuchs, Tuebingen, Germany |
| 08.45 – 09.05 | Keynote: How to find friends for rare pediatric tumors – Networking and professional structures built within Germany, Europe and beyond PD Dr. Ines Brecht, Tuebingen, Germany |
| 09.05 – 11.20 | Session 1: Pediatric Endocrine tumors Chair: N.N. Challenges of surgery on pediatric thyroid tumors Prof. Dr. Kerstin Lorenz, Halle, Germany Pediatric thyroid carcinomas – what´s new? Dr. Antje Redlich, Magdeburg, Germany Pediatric neuroendocrine tumors of the appendix – the new European Recommendations Prof. Dr. Jelena Roganovič, Zagreb, Croatia Steroid metabolomics in pediatric adrenocortical tumors Prof. Dr. Stefan Wudy, Giessen, Germany Diagnostic Utility of a Modified Reticulin Algorithm in Pediatric Adrenocortical Neoplasms Prof. Calogero Virgone, Padua, Italy The challenging task of complete tumor resection in advanced pediatric adrenocortical tumors Dr. Dr. Christoph Slavetinsky, Tuebingen, Germany The urge to find new therapeutic strategies for the treatment of advanced pediatric adrenocortical carcinoma Prof. Dr. Michaela Kuhlen, Augsburg, Germany Surgical management of pediatric thyroid neoplasms. Experience of a national pediatric onco-surgical reference center Dr. Cristian Urla, Tuebingen, Germany |
| 11.20 – 11.40 | Coffee Break |
| 11.40 – 12.50 | Session 2: Innovation and challenges in Diagnostics of rare pediatric tumors Chair: N.N. The challenge of the diagnosis of rare pediatric tumors Prof. Dr. Rita Aleggio, Rome, Italy Melanoma in prepuberal children: Diagnostic and therapeutic challenges Dr. Stephan Forchhammer, Tuebingen, Germany Methylation analysis for differentiation of classical melanoma from spitzoid melanoma in children and adolescents – a new approach Prof. Dr. Andreas von Deimling, Heidelberg, Germany Innovative advances in radiology for pediatric cancer patients Prof. Dr. Jürgen Schäfer, Tuebingen, Germany |
| 12.50 – 13.50 | Lunch Break |
| 13.50 – 14.50 | Session 3: Free talks Chair: N.N. xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx |
| 14.50 – 15.15 | Coffee Break |
| 15.15 – 17.15 | Session 4: DICER1-associated tumors Chair: N.N. The DICER-1 Tumour Syndrome Dr. KrisAnn Schulz, Minnesota, USA Relapsed pediatric pleuropulmonary blastoma – A European collaborative analysis Prof. Dr. Monika Sparber-Sauer, Stuttgart, Germany Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations Prof. Dr. Gianni Bisogno, Padua, Italy The International Pleuropulmonary blastoma Study – first transatlantic study on a rare pediatric tumor Dr. KrisAnn Schulz, Minnesota, USA Rare gonadal tumors in children and adolescents Prof. Dr. Dominik Schneider, Dortmund, Germany Zystic nephroma in the context of DICER1 predisposition Univ.-Prof. Dr. Norbert Graf, Homburg/Saar, Germany Advance in rhabdomyosarcoma occurring in DICER1 predisposition syndrome Dr. Nadège Corradini, Nantes, France |
| 18.30 | Congress Dinner → Restaurant 1821, Wilhelmstraße 3, 72074 Tübingen |
| Saturday, November 30th, 2024 | |
|---|---|
| 09.00 – 09.20 | Keynote: When adult cancers occur in children PD Dr. Andreas Block, Hamburg, Germany |
| 09.20 – 11.35 | Session 5: Ear, Nose and Throat tumors Chair: N.N. Salivary gland tumors in children and adolescents – data and treatment recommendations from the European cooperative study group for pediatric rare tumors Prof. Dr. Daniel Orbach, Paris, France Exploring cervical lymph node invasion characteristics and patterns of relapse in pediatric salivary gland malignancies: insight into therapeutic implications and long-term outcomes Dr. Celine Richard, St. Jude, USA Melanotic Neuroectodermal Tumor of Infancy Dr. Malgorzata Krawczyk, Gdansk, Poland Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma Univ.-Prof. Dr. Udo Kontny, Aachen, Germany The role of radiotherapy in head and neck tumors in children Prof. Dr. Beate Timmermann, Essen, Germany – to be confirmed Surgery of ENT tumors in children and adolescents Prof. Dr. Jens Peter Klußmann, Cologne, Germany – to be confirmed The EORTC-ESMO Guidelines for nasopharyngeal carcinoma Cristina Gurizzan, Italy Esthesioneuroblastoma Dr. Barbara Hero, Cologne, Germany |
| 11.35 – 11.55 | Coffee Break |
| 11.55 – 13.05 | Session 6: Pancreatic tumors Chair: N.N. Solid pseudopapillary neoplasms of the pancreas in childhood and adolescence – an analysis of the German Registry for Rare Pediatric Tumors Dr. Michael Abele, Tuebingen, Germany Update on neuroendocrine tumors of the pancreas Prof. Calogero Virgone, Padua, Italy Surgery of pancreatoblastoma and pancreatic carcinoma Prof. Dr. Jörg Fuchs, Tuebingen, Germany Treatment strategies for children with relapsed pancreatoblastoma Prof. Dr. Ewa Bien, Gdansk, Poland |
| 13.05 – 14.05 | Lunch Break |
| 14.05 – 15.20 | Session 7: Basic Research Chair: N.N. Etiology of pediatric melanoma in children and adolescents – first results from the EU MELCAYA project Anton Karelin, Tuebingen, Germany Preclinical modeling of rare solid tumors for clinical translation Dr. Roland Imle, Heidelberg, Germany Free talks |
| 15.20 – 15.40 | Coffee Break |
| 15.40 – 17.10 | Session 8: NUT carcinoma Chair: N.N. Clinicopathologic features and pathogenesis of NUT carcinoma – Data of the International NUT Carcinoma Registry Prof. Dr. Christopher Alexander French, Harvard Medical School, USA Pediatric NUT carcinoma in children and adolescents – data from the European cooperative study group for paediatric rare tumours Dr. Tim Flaadt, Tuebingen, Germany NUT Carcinoma in Children and Adolescents: The Expert European Standard Clinical Practice Harmonized Recommendations Dr. Lauriane Lemelle, Paris, France New targeted treatment approaches for NUT Carcinoma – an underdiagnosed and highly aggressive entity Prof. Dr. Ulrich Lauer, Tuebingen, Germany Studying spatial biology of NUT carcinoma with the multiplexed imaging platform MACSima™ Dr. Christian Seitz, Heidelberg, Germany |
| 17.10 | Closing remarks Prof. Dr. Johannes Schulte, Tuebingen, Germany |
